Interaction of Body Mass Index and Glycemic Status on Cardiovascular Outcomes in Patients With Cancer Treated With Anthracyclines

Interaction of Body Mass Index and Glycemic Status on Cardiovascular Outcomes in Patients With Cancer Treated With Anthracyclines

Background Anthracycline‐based chemotherapy is a vital treatment for various cancers but carries notable risks of cardiotoxicity. This study aimed to assess how different body mass index values and glycemic status influence the risk of major adverse cardiovascular events (MACE) in chemotherapy‐naïve...

Full description

Saved in:
Bibliographic Details
Main Authors: Iokfai Cheang, Xu Zhu, Xinyi Lu, Ying Li, Gehui Ni, Ying Yang, Yue Zhang, Qing‐Wen Ren, Mei‐Zhen Wu, Rongrong Gao, Kai‐Hang Yiu, Xinli Li
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anthracycline‐based chemotherapy
body mass index
cardiotoxicity
cardiovascular outcomes
glycemic status
heart failure
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.040876
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.124.040876

Similar Items